Acadia Pharmaceuticals | ACAD - ДОЛГ





ДОЛГ Изменить Дата
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
ALKERMES USD 1.58B 1.51B 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Cytokinetics USD 1.29B 4.48M 2026-03
Eisai JPY 186.08B 50.58B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Incyte USD 38.27M 1.16M 2026-06
J&J USD 54.99B 7.05B 2026-03
Moderna USD 1.3B 7M 2026-03
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Pfizer USD 63.19B 536M 2026-06
Prothena USD 7.65M 1.43M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06